FDA approves allergy treatment Zyrtec (cetirizine HCl) for over-the-counter use
McNeil Consumer Healthcare, a division of McNeil-PPC, has received approval for the allergy treatment Zyrtec (cetirizine HCl) to be used without a prescription for adults and children. Zyrtec relieves symptoms caused by perennial and seasonal allergic rhinitis, commonly referred to as indoor and outdoor upper respiratory allergies. Zyrtec also relieves itching due to hives. The approval comes one week after the FDA granted the company approval to market Zyrtec-D 12 Hour (cetirizine HCl 5 mg/pseudo ephedrine HCl 120 mg), which combines Zyrtec with a decongestant. Zyrtec-D and Zyrtec will be available OTC in late January 2008 in their original prescription strength. With Zyrtec's patent expiring this month, generic Rx versions are also expected to make their debut.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.
Examining Trends in Long-Term Opioid Use, Importance of Pharmacist-Physician Collaboration
March 27th 2024At APhA 2024, 2 posters looked into how collaboration between physicians and community pharmacists is crucial when it comes to opioid prescriptions, and current opioid use patterns among older adults.